Where Trusted Expertise Meets Real-World Impact
AscellaHealth is at the forefront of change, partnering with stakeholders across the health services industry to elevate and transform the patient journey. Stay up to date with the latest news, events, and media coverage as we continue to shape the future of healthcare.
Search
Search
Sort By
Newsroom
ClearCategories
ClearHealthcare—
Together
Transitioning Site of Care in Infusion Therapy: A Path Toward Optimization
As managing the costs of specialty healthcare continues to be a core focus for patients, providers, and payers, transitioning site of care delivery for patients requiring infusion therapy has become a topic of increasing interest.
Leveraging Data Insights and Analytics to Enhance Pharmacy HUB Services and Clinical Effectiveness
As access to meaningful healthcare data continues to expand, there is increasing momentum to equip pharmacy HUB services with actionable insights and analytics. These centralized services play a vital role in coordinating patient support, prior authorization, and adherence programs.
Weighing the Costs and Benefits of Breakthrough Cell and Gene Therapies
Specialty medications now account for over 75% of all drugs in development. These therapies present a forward-thinking approach to treating complex, chronic, and rare diseases, offering hope and potentially life-changing solutions for patients and healthcare providers.
Living With ITP: Mario's Journey with Idiopathic Thrombocytopenia Purpura
In observance of Rare Disease Month, AscellaHealth shines a light on the stories of patients with rare diseases. We recently interviewed Mario, an inspiring patient dealing with Idiopathic Thrombocytopenia Purpura (ITP), on our podcast, AscellaHealth Podcast Pulse.
Navigating the Value-Based Care Shift: Key Challenges for Payers (Part 2)
Part 2 of this series expands on previous insights, examines value-based care models and associated payment approaches, and highlights real-world examples of payers and manufacturers successfully implementing these innovative, performance-based strategies.
Navigating the Value-Based Care Shift: Key Challenges for Payers (Part 1)
This two-part series examines the shift from volume-based to value-based contracts in the healthcare industry and the impact this transition has on specialty drugs and cell and gene therapies (CGTs).
Leveraging Patient-Centric Solutions to Meet the Unmet Needs of Specialty Pharmaceutical Care
Specialty pharmaceutical healthcare is undergoing a transformative shift. To truly transform this landscape, we must prioritize patient-centric solutions that address these challenges head-on and elevate the standard of care.